In lymphocytes, downregulation of DOCK2 expression using sh-RNA leads to decreased proliferation of B-cell lymphoma cells, a mechanism related to DOCK2-mediated Rac-ERK (Wang et al., 2010; Sakamoto et al., 2017). The gene discussed is AKT1; the disease is B-cell non-Hodgkin lymphoma.